US Nuclear Corp Reports Significant Loss Reduction, Projects Profitability in Third Quarter
US Nuclear Corp announced a 54% reduction in net loss for the second quarter and forecasts profitability in the third quarter while expanding its nuclear fusion investments and sales operations.

US Nuclear Corp (OTC: UCLE) reported substantial financial improvement in its second quarter results, with net loss reduced by over 54% compared to previous periods. The company anticipates achieving profitability in the third quarter and expects continued positive momentum through 2026 due to an increasing backlog of orders. CEO Bob Goldstein emphasized that excluding non-cash charges and a delayed shipment, the company would have shown a net loss of less than $301,000 for the first half of 2025, representing a 49% reduction from the $617,404 loss recorded in the first half of 2024.
The company's strategic shift toward rejecting low-margin or high-risk projects has contributed to its improved financial performance. Goldstein noted that while second quarter results approached breakeven, the delayed shipment prevented the company from showing a small profit during that period. The company's detailed financial filings for the second quarter are accessible at https://www.sec.gov/edgar/searchedgar/companysearch, providing investors with comprehensive performance data.
US Nuclear Corp also completed significant transactions in the nuclear fusion sector following the second quarter closure. The company held 622,710 shares in MIFTI, an early-stage developer of thermonuclear fusion-powered reactors, and 2 million shares in MIFTEC, a sister company focused on radio-isotope technology. The September 2025 merger of these entities resulted in US Nuclear receiving 0.2 shares of MIFTI for each MIFTEC share owned, consolidating the company's position with 1,022,710 MIFTI shares. This strategic investment positions US Nuclear to capitalize on the growing nuclear fusion market while exploring additional opportunities in both fission and fusion reactor technologies.
The company is expanding its sales infrastructure to support growing customer demand. Nikki Truax, Director of Operations at Overhoff Technology, the company's primary manufacturing and sales operation, indicated active recruitment for sales representatives, distributors, and an experienced Vice President of Sales. The consolidation of product lines from Optron and ECC has created a comprehensive portfolio exceeding 250 distinct products, requiring expanded technical sales capabilities to maintain service quality. The company's operational details and product information can be found at https://www.overhoff.com, highlighting their expanded capabilities in nuclear detection and measurement technologies.